Neochem Reports 32% Revenue Growth In FY26, PAT Surges 62%
Specialty bio-solutions company Neochem has reported strong financial performance for the fiscal year ended March 31, 2026, driven by improved operational efficiencies and higher profitability across its business segments.
According to its audited standalone financial results, the company recorded total revenue of Rs 113.4 crore in FY26, registering a 32% year-on-year growth from Rs 84.17 crore in FY25.
Earnings before interest, taxes, depreciation and amortization (EBITDA) rose 53% year-on-year to Rs 22.6 crore, compared to Rs 14.76 crore in the previous fiscal. The company’s EBITDA margin improved significantly to 20.4%, up from 17.2% in FY25, representing an expansion of 312 basis points.
Net profit also witnessed strong growth, with Profit After Tax (PAT) increasing 62% to Rs 12.03 crore, compared to Rs 7.44 crore in FY25. PAT margin improved from 8.8% to 10.9%, reflecting an expansion of 210 basis points.
The company attributed the performance to its focus on specialized bio-based solutions, operational efficiency improvements and a strategy centered on value creation and profitability rather than volume-led growth.
Neochem said it remains committed to delivering sustainable and environmentally aligned solutions for customers while creating long-term value for stakeholders. The company expects to build on its FY26 momentum through continued innovation, operational excellence and expansion of its specialty product portfolio.
